- Home
- NINE vs VRCA Comparison
NINE vs VRCA Comparison
Compare NINE & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NINE | VRCA |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 32.7M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | NINE | VRCA |
|---|---|---|
| Price | $0.49 | $8.81 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 378.4K |
| Earning Date | 10-30-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $571,171,000.00 | $30,829,000.00 |
| Revenue This Year | $4.56 | $373.65 |
| Revenue Next Year | $1.41 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.59 | ★ 234.73 |
| 52 Week Low | $0.37 | $3.28 |
| 52 Week High | $1.78 | $12.00 |
Technical Indicators
Market Signals| Indicator | NINE | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 71.77 |
| Support Level | $0.42 | $6.26 |
| Resistance Level | $0.49 | $9.82 |
| Average True Range (ATR) | 0.04 | 1.02 |
| MACD | 0.01 | 0.42 |
| Stochastic Oscillator | 83.29 | 83.64 |
Price Performance
Historical ComparisonAbout NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.